Abstract In recent years, therapeutic monoclonal antibodies have made impressive progress, providing great benefit by successfully treating malignant and chronic inflammatory diseases
Retail prices without insurance are often high, and while some insurance plans cover these medications when prescribed for type 2 diabetes, coverage for weight loss purposes is typically more restricted
However, its use should always be guided by a healthcare provider familiar with your unique health history and needs
The results with semaglutide alone are encouraging and suggest a potential new treatment option for a group of patients who previously had very few. The Phase II trial followed about 700 adults with biopsy-confirmed MASH and moderate to advanced liver scarring, including participants who had already developed early cirrhosis
At the same time, patients needing these procedures often have obesity or diabetes, conditions that increase surgical risk